Coverage Universe
BSR maintains formal coverage on over two dozen development-stage biotechnology companies. Having a company in our coverage universe does not necessarily mean we see them as a good investment. Our opinions on the companies appearing below range from a belief they should be overweight in a diversified biotechnology portfolio to a determination they are not suitable for investment capital. Clicking on the name of the company takes you to a list of everything we've published on the company.


Company Ticker First coverage
Adolor ADLR March 2003
Altus Pharma ALTU September 2006
Amicus Therapeutics FOLD October 2007
BioMarin Pharmaceuticals BMRN October 2004
CombinatoRx CRXX January 2007
Corcept Therapeutics CORT September 2004
Dendreon DNDN February 2001
Discovery Labs DSCO October 2002
Dynavax DVAX July 2006
Hana Biosciences HNAB February 2006
Indevus Pharma IDEV February 2002
Medarex MEDX December 2003
Oncolytics Biotech ONCY June 2005
Osmetech AIM:OMH February 2008
OXiGENE OXGN July 2007
Pipex Pharmaceuticals PP September 2007
Repros Therapeutics RPRX February 2006
Resverlogix TSE:RVX April 2003
SciClone Pharma SCLN April 2003
Seattle Genetics SGEN June 2002
Sonus Pharma SNUS May 2003
Targeted Genetics TGEN August 2001
YM Biosciences YMI November 2005
ZymoGenetics ZGEN November 2002
Home

© 2006-2008 Biotech Stock Research, LLC. Use of this site is governed by the terms and conditions.